Skip to the page

Data / Form D filings / TriAgenics, Inc

TriAgenics, Inc: Form D filings

TriAgenics, Inc, a health care company in Redmond, OR, filed 4 Form D notices with the SEC between 2018 and 2025. The latest, on April 17, 2025, reports $500,000 sold of a $3 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
525 SW UMATILLA AVENUE, SUITE 102, Redmond, OR, 97756
Phone
(541) 543-3696
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1732710

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 17, 2025New notice$3,000,000$500,000$2,500,0001Apr 11, 2025sec.gov
Sep 2, 2021Amendment$2,502,500$1,912,302$590,19827Dec 15, 2020sec.gov
Aug 5, 2020New notice$1,802,500$0$1,802,5000Yet to occursec.gov
Mar 8, 2018New notice$1,500,000$1,400,000$100,0001Feb 23, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John Joseph ChopackDirector
David Scott ThrowerExecutive Officer, Director
Jeffrey Miles JacobsDirector
George Scott ShahinDirector
David Paul WastonDirector
Leigh ColbyExecutive Officer, Director

Other health care companies in Oregon that filed recently

Every Form D from the week of Apr 14, 2025 · All recent filings in Oregon · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what TriAgenics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.